APA citáció

Mantegazza Renato, Wolfe Gil I., Muppidi Srikanth, Wiendl Heinz, Fujita Kenji P., O'Brien Fanny L., . . . Rózsa Csilla. (2021). Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during regain and its open-label extension.

Chicago Style (17th ed.) Citation

Mantegazza Renato, et al. Post-intervention Status in Patients with Refractory Myasthenia Gravis Treated with Eculizumab During Regain and Its Open-label Extension. 2021.

MLA idézés

Mantegazza Renato, et al. Post-intervention Status in Patients with Refractory Myasthenia Gravis Treated with Eculizumab During Regain and Its Open-label Extension. 2021.